(Q94515815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

title

Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Atsushi Uchida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Hiroyuki Yonou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Eiri Hayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Kei Iha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Masami Oda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Minoru Miyazato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Yoshinori Oshiro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Sanehiro Hokama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

Yoshihide Ogawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

page(s)

275-279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

Modified induction course: a solution to side-effects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.10.017

10.1016/J.UROLOGY.2006.10.017

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17320663%20AND%20SRC:MED&resulttype=core&format=json